aTYR PHARMA (ATYR) Non-Current Debt (2014 - 2019)
aTYR PHARMA's (ATYR) quarterly Non-Current Debt came in at $2.7 million in Q3 2019, down 72.76% YoY from $10.1 million in Q3 2018, and down 40.39% on a QoQ basis from $4.6 million in Q2 2019.
aTYR PHARMA (ATYR) Non-Current Debt (2014 - 2019) Analysis & Trends
aTYR PHARMA (ATYR) has 6 years of Non-Current Debt data on file, last reported at $2.7 million in Q3 2019.
- Quarterly Non-Current Debt fell 72.76% year-over-year to $2.7 million in Q3 2019, while the trailing twelve-month figure through Sep 2019 was $2.7 million (down 72.76% YoY) and the FY2018 annual result came in at $8.3 million, down 43.86% from the prior year.
- Non-Current Debt retreated to $2.7 million in Q3 2019, from $4.6 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $14.7 million in Q4 2017 to a low of $896000.0 in Q1 2016.
- A 5-year average of $7.5 million and a median of $8.3 million in 2018 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2016 — Non-Current Debt plunged 79.27% — and 2017, when it surged 846.43%.
- Tracing ATYR's Non-Current Debt over 5 years: stood at $1.8 million in 2015, then surged by 417.91% to $9.2 million in 2016, then jumped by 60.02% to $14.7 million in 2017, then plunged by 43.86% to $8.3 million in 2018, then plunged by 66.82% to $2.7 million in 2019.
- The last three Non-Current Debt figures came in at $2.7 million (Q3 2019), $4.6 million (Q2 2019), and $6.4 million (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.65 Bn | 130.80 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.93 Bn | 77.94 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 64.84 Bn | 59.66 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.38 Bn | 52.25 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 882.16 Mn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.72 Bn | 9.33 Bn | 668.28 Mn | 360.97 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 8.96 Bn |
| 10 | aTYR PHARMA | 50.00 Mn | -7.42 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 2.74 Mn |
| Jun 30, 2019 | 4.60 Mn |
| Mar 31, 2019 | 6.44 Mn |
| Dec 31, 2018 | 8.26 Mn |
| Sep 30, 2018 | 10.07 Mn |
| Jun 30, 2018 | 11.85 Mn |
| Mar 31, 2018 | 12.95 Mn |
| Dec 31, 2017 | 14.72 Mn |
| Sep 30, 2017 | 12.48 Mn |
| Jun 30, 2017 | 11.79 Mn |
| Mar 31, 2017 | 8.48 Mn |
| Dec 31, 2016 | 9.20 Mn |
| Mar 31, 2016 | 896,000.00 |
| Dec 31, 2015 | 1.78 Mn |
| Sep 30, 2015 | 2.64 Mn |
| Jun 30, 2015 | 3.49 Mn |
| Mar 31, 2015 | 4.32 Mn |
| Dec 31, 2014 | 5.14 Mn |